Literature DB >> 7805782

Effects of Ca2+ channel antagonists on chromaffin cell death and cytosolic Ca2+ oscillations induced by veratridine.

R Maroto1, M T De la Fuente, A R Artalejo, F Abad, M G López, J García-Sancho, A G García.   

Abstract

Exposure of bovine chromaffin cells to 30 microM veratridine for 24 h led to 70-80% cell death as reflected by phase contrast microscopy, trypan blue exclusion, lactate dehydrogenase (LDH) release and cell catecholamine contents. Na+ deprivation, Ca2+ deletion or tetrodotoxin (5 microM) prevented the veratridine-induced cell damage. Nimodipine and verapamil, but not omega-conotoxin GVIA afforded 20-30% protection. Flunarizine protected the cells by 80% and R56865 by 60%. Stimulation of fura-2-loaded single bovine chromaffin cells with 30 microM of 1,1-dimethyl-4-phenylpiperazinium (DMPP) or 59 mM K+ caused fast increases in cytosolic Ca2+ concentrations, ([Ca2+]i). The [Ca2+]i rose from 0.1 to peaks of 1.9 microM, which quickly declined to near basal levels with a t1/2 of around 30 s. In spite of sustained stimulation with these two depolarizing agents, the [Ca2+]i remained low and did not undergo oscillations. In contrast, veratridine (30 microM) caused large and frequent oscillatory changes in the [Ca2+]i which were long-lasting and did not disappear even 30 min after washing out the toxin. The [Ca2+]i oscillations were reversibly suppressed by Na+ or Ca2+ removal and by 5 microM tetrodotoxin. Selective L-type Ca2+ channel blockers (10 microM nimodipine or verapamil) or N-type Ca2+ channel blockers (1 microM omega-conotoxin GVIA) did not affect the [Ca2+]i oscillations. In contrast, flunarizine or R56865 (10 microM each) suppressed the oscillations of [Ca2+]i. The results demonstrate that bovine chromaffin cells have the necessary machinery to develop prolonged and repetitive [Ca2+]i oscillations in the presence of veratridine; however, 'physiological' depolarizing stimuli did not cause oscillations.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7805782     DOI: 10.1016/0926-6917(94)90009-4

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  7 in total

Review 1.  Chromaffin cells as a model to evaluate mechanisms of cell death and neuroprotective compounds.

Authors:  Cristobal de Los Rios; Maria F Cano-Abad; Mercedes Villarroya; Manuela G López
Journal:  Pflugers Arch       Date:  2017-08-19       Impact factor: 3.657

2.  Old and emerging concepts on adrenal chromaffin cell stimulus-secretion coupling.

Authors:  Ricardo Borges; Luis Gandía; Emilio Carbone
Journal:  Pflugers Arch       Date:  2017-11-06       Impact factor: 3.657

3.  Veratridine induces apoptotic death in bovine chromaffin cells through superoxide production.

Authors:  J Jordán; M F Galindo; S Calvo; C González-García; V Ceña
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

4.  Cytotoxicity Models in Chromaffin Cells to Evaluate Neuroprotective Compounds.

Authors:  María F Cano-Abad; Manuela G López
Journal:  Methods Mol Biol       Date:  2023

5.  Neuroprotective Effect of the Novel Compound ITH33/IQM9.21 Against Oxidative Stress and Na(+) and Ca(2+) Overload in Motor Neuron-like NSC-34 Cells.

Authors:  Ana J Moreno-Ortega; Lamiaa Mouhid Al-Achbili; Elba Alonso; Cristóbal de Los Ríos; Antonio G García; Ana Ruiz-Nuño; María F Cano-Abad
Journal:  Neurotox Res       Date:  2016-04-28       Impact factor: 3.911

6.  Benzothiazepine CGP37157 and its isosteric 2'-methyl analogue provide neuroprotection and block cell calcium entry.

Authors:  Laura González-Lafuente; Javier Egea; Rafael León; Francisco J Martínez-Sanz; Leticia Monjas; Concepción Perez; Cristina Merino; Antonio M García-De Diego; María I Rodríguez-Franco; Antonio G García; Mercedes Villarroya; Manuela G López; Cristóbal de Los Ríos
Journal:  ACS Chem Neurosci       Date:  2012-03-26       Impact factor: 4.418

Review 7.  Stabilizers of neuronal and mitochondrial calcium cycling as a strategy for developing a medicine for Alzheimer's disease.

Authors:  José-Carlos Fernández-Morales; Juan-Alberto Arranz-Tagarro; Enrique Calvo-Gallardo; Marcos Maroto; Juan-Fernando Padín; Antonio G García
Journal:  ACS Chem Neurosci       Date:  2012-08-29       Impact factor: 4.418

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.